|
|
|
|
Philips To Unveil Breakthrough In Digital PathologyAt the United States & Canadian Academy of Pathology 2010 annual meeting (March 20-26, Washington DC, USA), Royal Philips Electronics (NYSE: PHG, AEX: PHI) will unveil a work-in-progress pathology slide scanner and associated image management system. These prototype systems will form the basis of the company's future integrated digital pathology solutions. The prototype slide scanner will be designed to overcome one of the major hurdles for mainstream introduction of digital pathology - the availability of a scanning technology that combines ease of use, speed and high image quality...
Source: Health News from Medical News Today | 21 Mar 2010 | 1:00 am Novelos Therapeutics Discontinues Current Development Program For NOV-002 In NSCLCNovelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, announced that primary and secondary endpoints were not met in Novelos' pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) with its lead product, NOV-002, in combination with first-line chemotherapy. Adding NOV-002 to paclitaxel and carboplatin chemotherapy was not statistically or meaningfully different in terms of efficacy-related endpoints or recovery from chemotherapy toxicity versus chemotherapy alone...
Source: Health News from Medical News Today | 21 Mar 2010 | 1:00 am Baxter And Its Foundation Expand Access To Healthcare And Education Through 2009 ContributionsBaxter International Inc., its employees and The Baxter International Foundation are committed to supporting global and local communities through financial contributions; product donations; employee volunteerism, including support of education; and other initiatives. In 2009, charitable giving exceeded $52 million to address critical needs locally and globally. Recent initiatives include supporting relief efforts in Haiti due to the devastating earthquake, and building Baxter's talent pipeline through a partnership with Howard University...
Source: Health News from Medical News Today | 21 Mar 2010 | 1:00 am NHS Needs To Invest In Increasing Specialists' Nurses, WalesThe Royal College of Nursing (RCN) has joined forces with almost 40 of the UK's leading health organisations to warn that cutting specialist nurse services for people with long term conditions would be a "false economy", as they began a campaign for guaranteed access to specialist nursing care for all patients with long term conditions. Specialist nurse posts save millions of pounds from health budgets through reduced complications, fewer hospital re-admissions and the expert long term management of conditions...
Source: Health News from Medical News Today | 21 Mar 2010 | 1:00 am FDA Advisory Panel Unanimously Recommends Expanded Indication For Boston Scientific's Heart Failure Devices Based On Landmark MADIT-CRT TrialBoston Scientific Corporation (NYSE: BSX) announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) has unanimously recommended approval of an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The panel recommended the expansion include the majority of the studied population of the landmark MADIT-CRT clinical trial, which evaluated the ability of these devices to slow the progression of heart failure in patients with asymptomatic or mild heart failure...
Source: Health News from Medical News Today | 21 Mar 2010 | 1:00 am Phase 2 Data On Provectus's PV-10 To Be Presented At The 2010 ASCO Scientific Program On June 4 - 8 In ChicagoProvectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced that data from its Phase 2 study of PV-10 for metastatic melanoma has been accepted for presentation at the 2010 American Society of Clinical Oncology (ASCO) Scientific Program to be held on June 4 - 8, 2010 in Chicago, Illinois. Dr. Sanjiv Agarwala, Chief, Medical Oncology and Hematology at St. Luke's Hospital and Health Network in Bethlehem, PA, and Principal Investigator for Provectus's Phase 2 PV-10 trial site at St...
Source: Health News from Medical News Today | 21 Mar 2010 | 1:00 am Avandia Debate "Skewed" By Pharmaceutical CompanyResearchers claim that pharmaceutical company GlaxoSmithkline has tried to influence the debate on the safety of diabetes treatment drug Avandia, also known as rosiglitazone, which the company manufactures. A new study claims that more than nine out of ten scientists who backed the drug had financial links to the pharmaceutical industry. Researchers from the Mayo Clinic in Minnesota analysed more than 200 articles published in scientific journals, including original papers, editorials and letters, which commented on the heart attack risk associated with Avandia after 2007...
Source: Health News from Medical News Today | 21 Mar 2010 | 1:00 am New Analysis Of Senate Health Reform Bill And President's Proposal Signal Significant Legal Changes AheadA new analysis of H.R. 3590, the Patient Protection and Affordable Care Act passed on December 24, 2009 by the United States Senate, was released today by The GW School of Public Health and Health Services, Hirsh Health Law and Policy Program. This new analysis focuses on key legal changes in the Senate-passed legislation and highlights relevant provisions addressed in the President's health reform proposal (released by the White House on February 22, 2010)...
Source: Health News from Medical News Today | 21 Mar 2010 | 1:00 am Varian Medical Systems To Showcase Image-Guided Radiotherapy, Radiosurgery, And X-ray Imaging Technologies At Major Medical Meetings In AsiaVarian Medical Systems, Inc...
Source: Health News from Medical News Today | 21 Mar 2010 | 1:00 am Boston Scientific Completes Enrollment In PLATINUM Trials For Small Vessels And Long LesionsBoston Scientific Corporation (NYSE: BSX) announced the completion of patient enrollment in the Small Vessel and Long Lesion trials of its PLATINUM clinical program. The trials are designed to compare the platinum chromium PROMUS® Element™ Everolimus-Eluting Stent System to matched historical control groups of patients treated with the TAXUS® Express2™ Paclitaxel-Eluting Stent System. The Small Vessel trial enrolled 94 patients with de novo lesions greater than or equal to 2.25 to less than 2.50 mm in diameter and less than or equal to 28 mm in length...
Source: Health News from Medical News Today | 21 Mar 2010 | 1:00 am Democrats Predict Slim Margin in Health Vote SundayDemocrats late Saturday night said the 216 votes needed to pass the bill were nearly within reach, but that the margin of victory would likely be razor thin.Source: NYT > Health | 21 Mar 2010 | 12:49 am Major retrospective for fashion genius Saint LaurentMany young women think of Yves Saint Laurent as a brand, they know nothing about him, says Farid Chenoune, one of the curators of the first major retrospective in 27 years devoted to the...Source: RSS feed - channel BNewsHealth | 20 Mar 2010 | 11:44 pm Haiti's cultural heritage faces quake extinctionBrilliant colors shine through the ruins of the Cathedrale de la Sainte-Trinite, fragments of wonderful murals that were the climax of Haiti's artistic explosion 60 years ago. For...Source: RSS feed - channel BNewsHealth | 20 Mar 2010 | 11:20 pm Nepalese doc is God of Sight to poorRaj Kaliya Dhanuk sits on a wooden bench, barefoot, with a tattered sari covering thin arms as rough as bark. Thick clear tears bleed from her eyes, milky saucers that stare at nothing. ...Source: RSS feed - channel BNewsHealth | 20 Mar 2010 | 10:01 pm Trial to begin in case of US surgeon charged in patient deaths at rural Australian hospitalBRISBANE, Australia - An American doctor charged with manslaughter in the deaths of three patients at a rural Australian hospital will go on trial Monday, accused of repeatedly botching...Source: RSS feed - channel BNewsHealth | 20 Mar 2010 | 8:55 pm Hip treatmentShock wave therapy gives golfer back her swingSource: BBC News | Health | World Edition | 20 Mar 2010 | 6:01 pm Novell rejects $2 bln Elliott Associates offerLOS ANGELES, March 20 (Reuters) - Novell Inc spurned a $2 billion takeover offer from investment fund Elliott Associates on Saturday, calling the bid inadequate and saying it undervalued the business...Source: RSS feed - channel BNewsHealth | 20 Mar 2010 | 5:04 pm Study: Lesser-known superbug more of a problem in Southern hospitals than MRSAATLANTA - As one superbug seems to be fading as a threat in hospitals, another is on the rise, a new study suggests. A dangerous, drug-resistant staph infection called MRSA is often...Source: RSS feed - channel BNewsHealth | 20 Mar 2010 | 3:06 pm White House Memo: For Obama, Health Care Pushes Other Issues to the MarginsFor several weeks the issue of health care has overshadowed every other issue, foreign and domestic, faced by President Obama.Source: NYT > Health | 20 Mar 2010 | 10:24 am UPDATE 2-Bharti board oks $9 bln offer for Zain Africa-Bloomberg* SingTel says Bharti board met, but no comment on contentSource: RSS feed - channel BNewsHealth | 20 Mar 2010 | 9:59 am Job Loss Takes a Toll on Mental HealthUnemployment is linked with higher rates of depression and other mental health problems.Source: Livescience.com - Health | 20 Mar 2010 | 8:20 am Study: Lesser-known bug a bigger hospital threatAs one superbug seems to be fading as a threat in hospitals, another is on the rise, a new study suggests. A dangerous, drug-resistant staph infection called MRSA is often seen as the...Source: RSS feed - channel BNewsHealth | 20 Mar 2010 | 7:12 am Study: Lesser-known bug a bigger hospital threat (AP)AP - As one superbug seems to be fading as a threat in hospitals, another is on the rise, a new study suggests.Source: Yahoo! News: Health News | 20 Mar 2010 | 7:12 am Study: Lesser-known germ a bigger hospital threatA new study finds that as one superbug seems to be fading as a threat in hospitals, another is on the rise. A study of 28 hospitals in the Southeast found that a dangerous,...Source: RSS feed - channel BNewsHealth | 20 Mar 2010 | 7:10 am
|